Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

554.27
Delayed Data
As of Aug 03
 +0.61 / +0.11%
Today’s Change
314.00
Today|||52-Week Range
569.91
+35.11%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 520.50, with a high estimate of 650.00 and a low estimate of 450.00. The median estimate represents a -6.09% decrease from the last price of 554.27.

Analyst Recommendations

The current consensus among 26 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.78
Sales
$887.6M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.47%
 
 
 
 
 
 
Growthannually 11.77%
 
 
 
 
 
 

Sales

Growthquarterly 2.07%
 
 
 
 
 
 
Growthannually 32.72%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.